🔎 Trials Near Me

Akèy › Skleroz Miltip › New York › New York City

Etid klinik pou Skleroz Miltip nan New York City, NY

17 etid pou Skleroz Miltip ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of the MIND Diet for Persons With Multiple Sclerosis

Ap rekrite
  • Mount Sinai Hospital, New York
Laj 18 a 70 · Tout sèks · Mizajou Oct 2, 2026 · NCT06992115

Vancomycin Study in Multiple Sclerosis (MS)

Ap rekriteFaz 1
  • Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
Laj 18 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT05539729

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Ap rekriteEtid obsèvasyon
  • TG Therapeutics Investigational Trial Site, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Ap rekriteFaz 1/2
  • Mt. Sinai, New York
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Ap rekriteFaz 2
  • NYU Langone Health, New York
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Ap rekriteFaz 1
  • TG Therapeutics Investigational Trial Site, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Ap rekriteFaz 1
  • Research Site, New York
  • Research Site, New York
Laj 18 a 60 · Tout sèks · Mizajou Aug 25, 2026 · NCT07224373

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Ap rekriteFaz 1
  • Columbia University Irving Medical Center, New York
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07304154

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Ap rekriteFaz 2
  • Mount Sinai School of Medicine, New York
Laj 18 a 60 · Tout sèks · Mizajou Jul 17, 2026 · NCT07497399

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

Ap rekriteFaz 2
  • NYU Langone Health, New York
Laj 18 a 65 · Tout sèks · Mizajou Jun 29, 2026 · NCT06901687

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mount Sinai Hospital, New York
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05982925

Genes and Environment in Multiple Sclerosis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Columbia University Irving Center, New York
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT01353547

A Palliative Care Model Impact on Knowledge and Attitudes

Ap rekrite
  • Judith Jaffe Multiple Sclerosis Center, New York
  • Hunter College, New York
Laj 18 a 65 · Tout sèks · Mizajou Apr 22, 2026 · NCT06860932

NYSCF Scientific Discovery Biobank

Ap rekriteEtid obsèvasyon
  • New York Stem Cell Foundation Research Institute, New York
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106

Eccentric Exercise and Fatigue in Multiple Sclerosis

Ap rekriteEtid obsèvasyon
  • Hunter College, Physical Therapy Department, City University of New York, New York
Laj 18 a 75 · Tout sèks · Mizajou Jul 17, 2024 · NCT06505421

Effect of Cooling on Balance Performance in Multiple Sclerosis

Ap rekriteEtid obsèvasyon
  • Hunter College, Physical Therapy Department, City University of New York, New York
Laj 18 a 75 · Tout sèks · Mizajou Nov 15, 2023 · NCT06094855

Etid Skleroz Miltip nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.